BIO-Europe Spring® 2016: What alliance opportunities excite Genentech?

June 22, 2016
Dr. Thomas Zioncheck, senior director of Genentech Partnering (a unit of Roche subsidiary Genentech Inc.), speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, during the BIO-Europe Spring® partnering conference in Stockholm, Sweden, about what alliances the company is seeking and how it beats off the competition for highly sought-after assets. Zioncheck explains what startups and biotechs need to bring to the table and why they need to bring those packages to Genentech. He also talks about Genentech's global search for new assets and its key therapy areas of interest.
Previous Video
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup

Dr. Ilan Zipkin, senior investment director at Takeda Ventures, talks with Mike Ward, global director of co...

Next Article
Single-use technology means big cost savings for bioprocessing industry
Single-use technology means big cost savings for bioprocessing industry

What does adoption of single-use technology mean for the bioprocessing industry?   The R&D and manufacturin...